Ascentage Pharma Group Corporation Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Ascentage Pharma Group Corporation's estimated annual revenue is currently $17.1M per year.
- Ascentage Pharma Group Corporation's estimated revenue per employee is $201,000
- Ascentage Pharma Group Corporation has 85 Employees.
- Ascentage Pharma Group Corporation grew their employee count by 29% last year.
- Ascentage Pharma Group Corporation currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Correct Rx Phar...||$16.5M||82||-6%||N/A|
|Factor One Sour...||$7.2M||36||29%||N/A|
What Is Ascentage Pharma Group Corporation?
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company's expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.keywords:N/A
Number of Employees
Employee Growth %
|Caroline Zhang||Manager, Ipo And Bd|
|Jason Gilmore||Director of Human Resources||Email Available|
|Robin Mulvey||Project Manager||Email Available|
|Piyush Sheladia||Sr. Project Manager||Email Available|
|Cindy Cao||Vice President, Head of Regulatory Affairs|
|Ying Zhang||Associate Directorï¼Œdata Management, Clinical Development||Email Available|
|Siobhan Solomon||Office Manager and Meeting/Event Planner with over 30 years experience||Email Available|
|Tom Knapp||SVP, General Counsel|
|Jeff Kmetz||Chief Business Officer||Email Available|
|Dajun Yang||Co-Founder, Chairman & Chief Executive Officer||Email Available|
Ascentage Pharma Group Corporation News
Global Bcl-2-Like Protein 1 Market Growth, Analysis, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.
Global Bcl-2-Like Protein 1 Market Analysis, Size, Share, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.
Top Key Players profiled in this report: AbbVie Inc, Ascentage Pharma Group Corp Ltd, Takeda Pharmaceutical Company Limited. Get FREE ...
Ascentage Pharma Group Corporation Executive Hires
|2019-02-15||Jeff Kmetz||Chief Business Officer||Article|
|2019-03-19||Thomas Knapp||SVP, General Counsel||Article|